In one study of OSCC patient tumor samples, it was observed that the majority of intratumor tumor-infiltrating lymphocytes (TILs) were CD8+ T cells (57); this is consistent with the findings in our canine OSCC study where high CD3+T cell-infiltrated tumors had significant overexpression of CD8a. The gene discussed is CD8A; the disease is neoplasm.